pharma · Cocaine-Related Disorders · Cocaine Dependence · DRUG
BRIGHT MINDS BIOSCIENCES
BRIGHT MINDS BIOSCIENCES INC.
BRIGHT MINDS BIOSCIENCES patent portfolio — 57 USPTO pharmaceutical patents (A61K/A61P) with grant dates, status, and loss-of-exclusivity filters.
Company details
- Status
- Public
- HQ
- 19 Vestry St, New York, NY 10013, US
- Employees
- 12
- Programs
- 1063
- Drugs
- 444
- Patents
- 57
BRIGHT MINDS BIOSCIENCES patents
57 pharmaceutical patents indexed for BRIGHT MINDS BIOSCIENCES. 4 expire within 24 months.
BRIGHT MINDS BIOSCIENCES has 57 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 4 expire within 24 months — use filters for patent-cliff planning.
Patent portfolio
-
US 8828407
Chimaeric protein
granted -
US 8507463
Nucleotide analogue prodrug and the preparation thereof
granted -
US 8501466
Vector
granted -
US 7935714
Compositions for sleeping disorders
granted -
US 7270994
Lactobacillus casei Bd-II stain and used to reduce blood cholesterol
granted -
US 7250182
Medicament containing Epimedium extract for treatment of prostatic hyperplasia and prostatitis
granted -
US 7205005
Medicament containing epidemium extract for treatment of prostatic hyperplasia and prostatitis
granted -
US 7192546
Methods of forming shaped articles from suspensions
granted -
US 6863693
Phospholipid-coated implants
expired
Frequently asked questions
How many patents does BRIGHT MINDS BIOSCIENCES have?
57 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).
When do BRIGHT MINDS BIOSCIENCES patents expire?
4 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.